1. Multidrug-resistant tumor cells with decreased malignancy: a role for integrin alphavbeta3.
- Author
-
Kozlova NI, Morozevich GE, Shtil AA, and Berman AE
- Subjects
- Animals, Cell Line, Tumor, Cricetinae, Neoplasm Invasiveness, Sarcoma, Avian secondary, Drug Resistance, Multiple, Extracellular Matrix metabolism, Integrin alphaVbeta3 metabolism, Matrix Metalloproteinase 2 metabolism, Sarcoma, Avian metabolism, Sarcoma, Avian pathology
- Abstract
We studied whether acquisition of multidrug resistance (MDR) by tumor cells can alter their integrin profile and malignant behavior. Hamster fibroblast cell line HET-SR-2SC-LNM was selected for MDR, yielding the 2SC/20 subline. Compared with the parental cells, the 2SC/20 subline weakly adhered to denatured collagen (dCol) which correlated with decreased expression of alphavbeta3, a dCol receptor. Importantly, 2SC/20 subline demonstrated significantly decreased activity of collagenase MMP-2, lower ability to invade Matrigel, and attenuated metastasis in syngeneic animals. We provide evidence for the first time that selection for MDR can be associated with down-regulation of alphavbeta3 integrin, supporting our recent proof of the pro-apoptotic role of this integrin (Oncogene 20 (2001) 4710). Lack of alphavbeta3 expression may link cell survival under toxic conditions with decreased malignancy of the resulting drug resistant tumor.
- Published
- 2004
- Full Text
- View/download PDF